MLL-ALL cells obtained from engrafted recipients were incubated with dexamethasone and RK-20449 plus various concentrations of ABT-199, a BCL-2 inhibitor (Fig. 4b) [37,38]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.